Eli Lilly (United States)
Relevante Arbeiten
Meistzitierte Publikationen im Bereich Gesundheit & MedTech
Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making
Alan Brnabic, Lisa M. Hess
2021 · 115 Zit.
Automation Opportunities in Pharmacovigilance: An Industry Survey
Rajesh Ghosh, Dieter Kempf, Angela Pufko et al.
2020 · 47 Zit.
Large Language Models and Their Applications in Drug Discovery and Development: A Primer
James Lu, Keunwoo Choi, Maksim Eremeev et al.
2025 · 14 Zit.
The role of the data coordinating center in the DIG trial
William O. Williford, Joseph F. Collins, Anne Horney et al.
2003 · 8 Zit.
Methods Used for the Applicability of Real-World Data Sources to Individual Patient Decision Making
Alan Brnabic, LM Hess, G Cuyun Carter et al.
2018 · 3 Zit.
Lessons learned from the DIG trial
Debra Egan, Nancy L. Geller, Salim Yusuf et al.
2003 · 2 Zit.
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
Michael M. Witte, Norman L. Foster, Adam Fleisher et al.
2015 · 0 Zit.
Use of AI within COA linguistic validation and eCOA migration processes: analysis and good practice recommendations
S. McKown, Benjamin F. Arnold, Frederique Boucher et al.
2026 · 0 Zit.
Abstract 4360716: An Artificial Intelligence Model for Clinical Event Adjudication in Cardiovascular Clinical Trial
Hiya Banerjee, Pierluigi Tricoci, Min Jiang et al.
2025 · 0 Zit.